特布他林、布地奈德联合噻托溴铵治疗慢性阻塞性肺病急性加重期的临床研究

Clinical study of Terbutaline,Budesonide and Tiotropium Bromide in Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease

目的研究特布他林、布地奈德联合噻托溴铵治疗慢性阻塞性肺疾病急性加重期的效果。方法将120例慢性阻塞性肺疾病急性加重期患者随机分为观察组(加用噻托溴铵粉吸入治疗)与对照组(常规治疗)各60例,对比两组患者疗效。结果观察组患者的总有效率明显高于对照组(P<0.05)。结论特布他林、布地奈德联合噻托溴铵治疗慢性阻塞性肺疾病急性加重期患者有效性高,可推广。

Objective To study terbutaline. Effect of budesonide combined with tiotropium bromide on acute exacerbation of chronic obstructive pulmonary disease. Methods 120 patients with acute exacerbation of chronic obstructive pulmonary disease were randomly divided into two groups. 60 cases were treated with tiotropium bromide powder inhalation and 60 cases with control group(routine treatment). Results The total effective rate in the observation group was significantly higher than that in the control group(P<0.05). ConclusionBudesonide combined with tiotropium bromide is effective in the treatment of patients with acute exacerbation of chronic obstructive pulmonary disease.